The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a
Background CD47 is a broadly expressed cell surface glycoprotein associated with immune evasion. Interaction with the inhibitory receptor signal regulatory protein alpha (SIRPα), primarily expressed on myeloid cells, normally serves to restrict effector function (eg, phagocytosis and immune cell hom...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
BMJ Publishing Group
2020-05-01
|
| 叢編: | Journal for ImmunoTherapy of Cancer |
| 在線閱讀: | https://jitc.bmj.com/content/8/1/e000413.full |